Phenotypic alterations of neurons that innervate osteoarthritic joints in rats.
OBJECTIVE
Pain is a prominent feature of osteoarthritis (OA). To further understand the primary mechanisms of nociception in OA, we studied the expression of the phenotype markers calcitonin gene-related peptide (CGRP), isolectin B4 (IB4), and neurofilament 200 (NF200) in sensory neurons innervating the OA knee joint in rats.


METHODS
OA was induced in rats by intraarticular injection of 2 mg of mono-iodoacetate (MIA) into the knee. Neurons innervating the joint were identified by retrograde labeling with fluorogold in dorsal root ganglia (DRG) and colocalized with neurochemical markers by immunofluorescence. The total number of DRG cells was determined by stereologic methods in Nissl-stained sections.


RESULTS
A 37% decrease in the number of fluorogold-backlabeled cells was observed in rats with OA when compared with control rats, even though no decrease in the total number of cells was observed. However, an increase in the number of medium/large cell bodies and a decrease in the number of the smallest cells were observed, suggesting the occurrence of perikarya hypertrophy. The percentage of CGRP-positive cells increased significantly, predominantly in medium/large cells, suggesting the occurrence of a phenotypic switch. Colocalization of CGRP and NF200 revealed no significant changes in the percentage of double-labeled cells, but an increase in the number of medium/large double-labeled cells was observed. No differences in the expression of either IB4 or NF200 were observed in fluorogold-backlabeled cells.


CONCLUSIONS
These results indicate that MIA-induced OA causes an up-regulation of CGRP in different subpopulations of primary afferent neurons in DRG due to a phenotypic switch and/or cell hypertrophy which may be functionally relevant in terms of the onset of pain in this pathologic condition.
Ferreira-Gomes
Joana
J
University of Porto, Porto, Portugal. jogomes@med.up.pt
Adães
Sara
S
Sarkander
Jana
J
Castro-Lopes
José M
JM
D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism; D004195:Disease Models, Animal; D006023:Glycoproteins / Q000378:metabolism; D006984:Hypertrophy; D007461:Iodoacetates / Q000009:adverse effects; D007719:Knee Joint / Q000294:innervation*; D037102:Lectins / Q000378:metabolism; D008297:Male; D016900:Neurofilament Proteins / Q000378:metabolism; D010003:Osteoarthritis / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology*; D010146:Pain / Q000378:metabolism; D010641:Phenotype; D051381:Rats; D017208:Rats, Wistar; D011984:Sensory Receptor Cells / Q000378:metabolism* / Q000473:pathology*; D053675:Versicans
D015415:Biomarkers; D006023:Glycoproteins; D007461:Iodoacetates; D037102:Lectins; D016900:Neurofilament Proteins; C508324:Vcan protein, rat; C051774:neurofilament protein H; D053675:Versicans; D015740:Calcitonin Gene-Related Peptide